No Data
No Data
List of converted stocks (Part 2) [List of converted stocks for Parabolic Signal]
○ List of sell conversion stocks Market Code Stock Name Closing Price SAR Tokyo main board <1762> Takamatsu G 2903 2979 <1773> YTL6981 <1833> Okumura Construction 39254395 <1882> Toa Road 12371309 <1888> Wakabuki Construction 34953700 <2150> Carenet 648688 <2217> Morozov 45804675 <2384> SBSHD 24082480 <2
List of stocks with cleared clouds (Part 2) [Ichimoku Kinko Hyo: List of Stocks with Cleared Clouds]
List of stocks breaking through the cloud market Code Stock name Closing price Leading Span A Leading Span B Tokyo Main Board <1882> Toad East Asia 1237 1375.5 1239 <1968> Taihei Electric 50305341.25 5032.5 <2127> Japan M&A 658662.25 722 <2181> Persol HD 243268.25 244.5 <2229> Calbee 31393381.25
Volume change rate ranking (9 o'clock) - Micronics, Media Link, etc. ranked in.
In the volume change rate ranking, by comparing the average volume of the last 5 days with the volume on the day of distribution, you can understand the interests of market participants such as trends in speculative trading. Top volume change rate [as of 9:32 on November 12] (comparison with the average volume of the last 5 days) Stock Code Stock Name Volume 5-Day Average Volume Volume Change Rate Stock Price Change Rate <6640> I・PEX 556700 10718 5.08 300.42% 0.23 13% <6659> Mede
Recruit HD, 2Q operating profit increased by 13.4% to 269.7 billion yen
Recruit HD <6098> announced that the second quarter performance for the quarter ending March 2025 showed sales revenue increased by 5.4% year-on-year to 1.7987 trillion yen, and operating profit increased by 13.4% to 269.8 billion yen. All HR technology business, matching & solution business, and temporary staffing business reported revenue growth. It exceeded the consensus of around 255 billion yen. Operating profit for the fiscal year ending March 2025 was revised upwards from 390 billion yen to 442.7 billion yen. Consensus.
Medical Data Vision: Revision of full-year consolidated earnings forecasts and medium-term management plans
Medical Data Vision: Financial results presentation materials for the 3rd quarter of the fiscal year ending 2024/12
No Data
No Data